You are here

Article info

Article menu

Download PDFPDF

Oncolytic and local immunotherapy
Live attenuated bacterium limits cancer resistance to CAR-T therapy by remodeling the tumor microenvironment

Authors

  • Fengguang Guo Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77802, USA PubMed articlesGoogle scholar articles
  • Jugal K Das Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77802, USA PubMed articlesGoogle scholar articles
  • Koichi S Kobayashi Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77802, USADepartment of Immunology, Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Japan PubMed articlesGoogle scholar articles
  • Qing-Ming Qin Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77802, USA PubMed articlesGoogle scholar articles
  • Thomas A Ficht Department of Veterinary Pathobiology, College of Veterinary Medicine, Texas A&M University, College Station, TX 77843, USA PubMed articlesGoogle scholar articles
  • Robert C Alaniz Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77802, USA PubMed articlesGoogle scholar articles
  • Jianxun Song Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77802, USA PubMed articlesGoogle scholar articles
  • Paul De Figueiredo Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77802, USADepartment of Veterinary Pathobiology, College of Veterinary Medicine, Texas A&M University, College Station, TX 77843, USA PubMed articlesGoogle scholar articles

Citation

Guo F, Das JK, Kobayashi KS, et al
Live attenuated bacterium limits cancer resistance to CAR-T therapy by remodeling the tumor microenvironment
Journal for ImmunoTherapy of Cancer 2022;10:e003760. doi: 10.1136/jitc-2021-003760
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.